REALISE Trial and Ruxolitinib Dosing Strategy

Opinion
Video

Dr. Bose discusses the REALISE trial and its implications for ruxolitinib dosing strategy, particularly in terms of safety and efficacy, and the purpose of this dosing strategy assessment in this patient population.

Recent Videos
2 KOLs are featured in this program.
2 KOLs are featured in this program.
2 KOLs are featured in this program.
2 KOLs are featured in this program.
2 KOLs are featured in this program.
2 KOLs are featured in this program.
1 KOL is featured in this series.
2 KOLs are featured in this program.